The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation, Health Technology Assessment, Vol:19, Iss:87

Authors: Nicholson A, Mahon J, Boland A, Beale S, Dwan K, Fleeman N, Hockenhull J, Dundar Y.
Source: NIHR Journals Library - Category: Global & Universal Source Type: research